Medxy AI

Precision Prediction of Incident Heart Failure: The Clinical Integration of AI-Enabled Electrocardiography

By MedXY 03/09/2026

This review evaluates the breakthrough ECG2HF model, a publicly available AI tool that outperforms standard clinical scores in predicting 10-year heart failure risk using 12-lead ECG waveforms.

Cardiology Neurology news

Long-Term Efficacy and Safety of Transcatheter Patent Foramen Ovale Closure: A 20-Year Follow-Up Study

By MedXY 03/09/2026

A 20-year follow-up study of 130 patients demonstrates that transcatheter PFO closure is highly effective in preventing recurrent strokes, though long-term antithrombotic therapy increases bleeding risks, particularly in women.

Cardiology news Pathology & Lab Medicine/Bệnh học

Inhibiting Myeloid-PlexinD1: A Novel Strategy to Stabilize Atherosclerosis at High-Risk Vascular Bifurcations

By MedXY 03/09/2026

Research reveals that PlexinD1 mediates macrophage-driven inflammation in response to disturbed blood flow. By targeting this pathway, scientists have successfully attenuated plaque progression in preclinical models, paving the way for advanced diagnostic imaging and precision therapies in cardiovascular medicine.

Cardiology news

Long-Term Superiority of Intravascular Imaging: 5-Year Results from the RENOVATE-COMPLEX-PCI Trial

By MedXY 03/09/2026

A 5-year follow-up of the RENOVATE-COMPLEX-PCI trial demonstrates that intravascular imaging-guided PCI significantly reduces major adverse cardiac events by 32% compared to angiography alone in complex lesions, highlighting the long-term clinical benefits of procedural optimization.

Clinical Updates news

Genotype-Phenotype Divergence in Hypertrophic Cardiomyopathy: Deciphering the Trajectories of Sarcomeric and Nonsarcomeric Disease

By MedXY 03/09/2026

This review analyzes the SHaRe registry data, revealing that sarcomeric HCM represents a more aggressive clinical phenotype with earlier onset and higher HCM-related mortality compared to nonsarcomeric cases, which are more heavily influenced by modifiable metabolic comorbidities.

news Oncology Otorhinolaryngology

Long-Term Survival Gains with Tislelizumab: Redefining First-Line Therapy for Metastatic Nasopharyngeal Carcinoma

By MedXY 03/09/2026

The 3-year follow-up of the RATIONALE-309 trial demonstrates that first-line tislelizumab plus chemotherapy significantly improves overall survival (45.3 months) in recurrent or metastatic nasopharyngeal carcinoma, identifying B-cell signatures as a key predictor of response.

Gastroenterology news Oncology

Unmasking DARS1: A Dual-Action Driver of Hepatocellular Carcinoma Aggressiveness via SAGA-MYC Signaling

By MedXY 03/08/2026

Researchers have identified DARS1 as a critical oncogenic driver in hepatocellular carcinoma. Beyond its role in protein synthesis, DARS1 enters the nucleus to modulate MYC signaling through the SAGA complex, offering a new therapeutic vulnerability and a potential liquid biopsy biomarker.

Clinical Updates Infectious Diseases news

Potent Inhibition of Hepatitis E Virus Replication by Bemnifosbuvir: Preclinical Evidence and Clinical Prospects

By MedXY 03/08/2026

Preclinical studies demonstrate that the nucleotide analogue bemnifosbuvir effectively suppresses Hepatitis E virus (HEV) replication, showing synergistic potential with ribavirin and a high genetic barrier to resistance.

Gastroenterology news Oncology

The Tryptophan Tug-of-War: How Faecalibacterium prausnitzii Counteracts Bacteroides fragilis in Colorectal Cancer

By MedXY 03/08/2026

A comprehensive multi-omics study reveals that Faecalibacterium prausnitzii metabolizes tryptophan into picolinic acid, which antagonizes the pro-tumorigenic effects of enterotoxigenic Bacteroides fragilis by down-regulating TCERG1 and CKAP2 genes, suggesting a potential dietary intervention for colorectal cancer.

Clinical Updates Neurology news

Differential Pathophysiological Roles of Centrum Semiovale Perivascular Spaces in Cerebral Amyloid Angiopathy and Deep Perforator Arteriopathy: A Biomarker Synthesis

By MedXY 03/08/2026

This review synthesizes evidence distinguishing perivascular space enlargement mechanisms in cerebral amyloid angiopathy (CAA) versus deep perforator arteriopathy (DPA), highlighting the diagnostic utility of CSF Aβ42/40 ratios in vascular amyloid pathology.

Clinical Updates General Surgery news

Therapeutic Potential of Autologous Blood Derivatives in Tissue Regeneration: A Systematic Review of Clinical Evidence and Mechanistic Insights

By MedXY 03/08/2026

This review synthesizes recent PubMed-indexed evidence on autologous blood-derived therapies, such as PRP and PRF, highlighting their role in accelerating wound healing through growth factor signaling and cellular recruitment.

$Minimally Invasive Endoscopic Techniques Redefine Recovery in Infraclavicular Brachial Plexus Management$

Neurology news Orthopedics

Minimally Invasive Endoscopic Techniques Redefine Recovery in Infraclavicular Brachial Plexus Management

By MedXY 03/08/2026

Recent clinical evidence demonstrates that endoscopic and arthroscopic techniques for infraclavicular brachial plexus neurolysis and pectoralis minor release provide comparable outcomes to open surgery with significantly reduced morbidity for both traumatic injuries and neurogenic thoracic outlet syndrome.

Clinical Updates Neurology news

Treatment Evolution in 5q-Spinal Muscular Atrophy: Real-World Evidence and Clinical Insights from the SMArtCARE Registry

By MedXY 03/08/2026

This review analyzes the shifting landscape of SMA therapy using data from 2,140 patients, highlighting the transition between nusinersen, risdiplam, and onasemnogene abeparvovec and the factors driving treatment switches.

Dermatology news Urology

Navigating Scrotal Health: A Comprehensive Guide to Lymphedema and Excessive Sweating

By MedXY 03/08/2026

This article provides an in-depth exploration of scrotal lymphedema and hyperhidrosis, detailing their physiological causes, clinical symptoms, and the latest management strategies for both patients and healthcare providers.

Clinical Updates Neurology news Rheumatology

Mapping the Genomic Landscape of Multiple Sclerosis Across Diverse Ancestries: Insights into Shared and Population-Specific Susceptibility

By MedXY 03/08/2026

This study demonstrates that while MS genetic risk factors are largely shared across ancestral groups, their predictive power and population-level impact vary significantly between European, South Asian, and African populations.

Clinical Updates Neurology news

Low-Dose Lithium for Mild Cognitive Impairment: A Pilot Randomized Clinical Trial and Synthesis of Emerging Neuroprotective Paradigms

By MedXY 03/08/2026

This review evaluates a recent 2-year pilot RCT on low-dose lithium carbonate for MCI, synthesizing its findings with emerging evidence on Aβ clearance, gut-brain axis modulation, and multimodal disease forecasting.

Neurology news Pediatrics

Fordadistrogene Movaparvovec Fails to Improve Functional Outcomes in Duchenne Muscular Dystrophy: Insights from the Phase 3 CIFFREO Trial

By MedXY 03/08/2026

The Phase 3 CIFFREO trial found that the gene therapy fordadistrogene movaparvovec did not significantly improve motor function in boys with Duchenne muscular dystrophy compared to placebo, leading to the discontinuation of its clinical development due to a negative benefit-risk profile.

Clinical Updates news

Comparative Diagnostic Performance of Global Thyroid Ultrasound Risk Stratification Systems: The Impact of Nodule Size and Lexicon Standardization

By MedXY 03/08/2026

This review synthesizes findings from a large-scale comparison of five major thyroid ultrasound risk stratification systems (RSSs), evaluating how nodule size and standardized lexicon influence sensitivity, specificity, and unnecessary biopsy rates.

Diabetes & Endocrinology news Pediatrics

Deciphering ZnT8A: Why Not All Islet Autoantibodies Predict Type 1 Diabetes Risk

By MedXY 03/07/2026

The ENDIA cohort study reveals that persistent single ZnT8 autoantibodies detected only via ELISA after age 4 do not significantly increase Type 1 Diabetes risk, whereas earlier detection across multiple assay formats signals higher progression probability.

Diabetes & Endocrinology news Pediatrics

24-Weekly vs. 12-Weekly Triptorelin: Clinical Equivalence and Enhanced Adherence in Central Precocious Puberty

By MedXY 03/07/2026

A UK multicentre study demonstrates that 24-weekly Decapeptyl SR is as effective and well-tolerated as the 12-weekly regimen for central precocious puberty, offering improved patient satisfaction and reduced clinical burden.